

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * drug transmembrane transport (GO:0006855) | 8.75681562 |
| 2 | urate metabolic process (GO:0046415) | 8.46874619 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.31615820 |
| 4 | * drug transport (GO:0015893) | 7.18624334 |
| 5 | organic cation transport (GO:0015695) | 6.47945026 |
| 6 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 6.09617004 |
| 7 | lysine metabolic process (GO:0006553) | 5.81476908 |
| 8 | lysine catabolic process (GO:0006554) | 5.81476908 |
| 9 | protein K11-linked deubiquitination (GO:0035871) | 5.67072048 |
| 10 | phosphate ion transport (GO:0006817) | 5.56643569 |
| 11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.40858801 |
| 12 | seminiferous tubule development (GO:0072520) | 5.39710571 |
| 13 | toxin transport (GO:1901998) | 5.26062524 |
| 14 | renal absorption (GO:0070293) | 5.20425406 |
| 15 | glycoside metabolic process (GO:0016137) | 5.13825161 |
| 16 | valine metabolic process (GO:0006573) | 5.06536161 |
| 17 | drug catabolic process (GO:0042737) | 5.04087614 |
| 18 | tricarboxylic acid metabolic process (GO:0072350) | 4.98963688 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.91241907 |
| 20 | branched-chain amino acid metabolic process (GO:0009081) | 4.88820881 |
| 21 | exogenous drug catabolic process (GO:0042738) | 4.86114465 |
| 22 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.77245940 |
| 23 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.68315454 |
| 24 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.68315454 |
| 25 | indolalkylamine catabolic process (GO:0046218) | 4.57481455 |
| 26 | tryptophan catabolic process (GO:0006569) | 4.57481455 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.57481455 |
| 28 | quaternary ammonium group transport (GO:0015697) | 4.55536039 |
| 29 | behavioral response to nicotine (GO:0035095) | 4.54912264 |
| 30 | synaptic transmission, dopaminergic (GO:0001963) | 4.54724171 |
| 31 | short-chain fatty acid metabolic process (GO:0046459) | 4.50534411 |
| 32 | aromatic amino acid family catabolic process (GO:0009074) | 4.48494162 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.46047018 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.43567645 |
| 35 | cysteine metabolic process (GO:0006534) | 4.39880829 |
| 36 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.35807750 |
| 37 | dendritic spine morphogenesis (GO:0060997) | 4.34485413 |
| 38 | phosphate ion transmembrane transport (GO:0035435) | 4.32870229 |
| 39 | proline metabolic process (GO:0006560) | 4.30977671 |
| 40 | branched-chain amino acid catabolic process (GO:0009083) | 4.29197431 |
| 41 | L-phenylalanine metabolic process (GO:0006558) | 4.27919343 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.27919343 |
| 43 | neural tube formation (GO:0001841) | 4.26749668 |
| 44 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 4.23847306 |
| 45 | vitamin D metabolic process (GO:0042359) | 4.23520391 |
| 46 | glutathione biosynthetic process (GO:0006750) | 4.22862564 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.19325991 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 4.19325991 |
| 49 | peptide catabolic process (GO:0043171) | 4.18854775 |
| 50 | enteric nervous system development (GO:0048484) | 4.15350122 |
| 51 | positive regulation of mitochondrial fission (GO:0090141) | 4.13995241 |
| 52 | excretion (GO:0007588) | 4.08385828 |
| 53 | trivalent inorganic anion homeostasis (GO:0072506) | 4.02478706 |
| 54 | phosphate ion homeostasis (GO:0055062) | 4.02478706 |
| 55 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.02059907 |
| 56 | nucleoside diphosphate catabolic process (GO:0009134) | 4.01095744 |
| 57 | righting reflex (GO:0060013) | 3.98975312 |
| 58 | cell differentiation involved in metanephros development (GO:0072202) | 3.96935663 |
| 59 | response to mercury ion (GO:0046689) | 3.95944824 |
| 60 | tooth mineralization (GO:0034505) | 3.93532985 |
| 61 | positive regulation of RNA splicing (GO:0033120) | 3.87195604 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 3.84718890 |
| 63 | metanephric nephron tubule development (GO:0072234) | 3.82274304 |
| 64 | metanephric tubule development (GO:0072170) | 3.82274304 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.81868654 |
| 66 | fatty acid beta-oxidation (GO:0006635) | 3.78210608 |
| 67 | carnitine metabolic process (GO:0009437) | 3.76018221 |
| 68 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.73116788 |
| 69 | regulation of pigment cell differentiation (GO:0050932) | 3.71618820 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 3.66728793 |
| 71 | reflex (GO:0060004) | 3.58800739 |
| 72 | aspartate family amino acid catabolic process (GO:0009068) | 3.58501157 |
| 73 | oligosaccharide catabolic process (GO:0009313) | 3.57033751 |
| 74 | detection of light stimulus involved in visual perception (GO:0050908) | 3.56400115 |
| 75 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.56400115 |
| 76 | peptide biosynthetic process (GO:0043043) | 3.56389783 |
| 77 | primary amino compound metabolic process (GO:1901160) | 3.54701553 |
| 78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.54387587 |
| 79 | fatty acid oxidation (GO:0019395) | 3.53227605 |
| 80 | fucose metabolic process (GO:0006004) | 3.48428051 |
| 81 | lipid oxidation (GO:0034440) | 3.48246749 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.47812054 |
| 83 | metanephric nephron epithelium development (GO:0072243) | 3.43153202 |
| 84 | positive regulation of protein sumoylation (GO:0033235) | 3.43078802 |
| 85 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.42565675 |
| 86 | indole-containing compound metabolic process (GO:0042430) | 3.42119328 |
| 87 | aromatic amino acid family metabolic process (GO:0009072) | 3.40373507 |
| 88 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.39339822 |
| 89 | activation of protein kinase A activity (GO:0034199) | 3.39023124 |
| 90 | behavioral response to ethanol (GO:0048149) | 3.38182401 |
| 91 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.38180699 |
| 92 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.30812447 |
| 93 | kynurenine metabolic process (GO:0070189) | 3.28812193 |
| 94 | fatty acid catabolic process (GO:0009062) | 3.27728950 |
| 95 | protein localization to synapse (GO:0035418) | 3.24982120 |
| 96 | fructose metabolic process (GO:0006000) | 3.24976753 |
| 97 | response to pheromone (GO:0019236) | 3.22730983 |
| 98 | metanephric epithelium development (GO:0072207) | 3.17585778 |
| 99 | icosanoid secretion (GO:0032309) | 3.16765762 |
| 100 | arachidonic acid secretion (GO:0050482) | 3.16765762 |
| 101 | peristalsis (GO:0030432) | 3.16392384 |
| 102 | serotonin metabolic process (GO:0042428) | 3.15412038 |
| 103 | alkaloid metabolic process (GO:0009820) | 3.14317344 |
| 104 | detection of chemical stimulus (GO:0009593) | 3.13342075 |
| 105 | amine catabolic process (GO:0009310) | 3.10842174 |
| 106 | cellular biogenic amine catabolic process (GO:0042402) | 3.10842174 |
| 107 | platelet dense granule organization (GO:0060155) | 3.10521672 |
| 108 | cellular amino acid catabolic process (GO:0009063) | 3.08661352 |
| 109 | hindbrain development (GO:0030902) | 3.08159789 |
| 110 | aldehyde catabolic process (GO:0046185) | 3.07216666 |
| 111 | monocarboxylic acid catabolic process (GO:0072329) | 3.06906944 |
| 112 | vocalization behavior (GO:0071625) | 3.04246030 |
| 113 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.02792589 |
| 114 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.02792589 |
| 115 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.02137363 |
| 116 | negative regulation of astrocyte differentiation (GO:0048712) | 2.97441629 |
| 117 | chemosensory behavior (GO:0007635) | 2.97212380 |
| 118 | beta-amyloid metabolic process (GO:0050435) | 2.96983255 |
| 119 | glutathione metabolic process (GO:0006749) | 2.96778319 |
| 120 | response to phenylpropanoid (GO:0080184) | 2.96661134 |
| 121 | serine family amino acid catabolic process (GO:0009071) | 2.95966977 |
| 122 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.95700771 |
| 123 | alpha-amino acid catabolic process (GO:1901606) | 2.95024102 |
| 124 | carnitine transport (GO:0015879) | 2.94616560 |
| 125 | amino-acid betaine transport (GO:0015838) | 2.94616560 |
| 126 | carboxylic acid catabolic process (GO:0046395) | 2.93853972 |
| 127 | organic acid catabolic process (GO:0016054) | 2.93853972 |
| 128 | nephron tubule development (GO:0072080) | 2.93303598 |
| 129 | cilium movement (GO:0003341) | 2.91847082 |
| 130 | polyol catabolic process (GO:0046174) | 2.91376944 |
| 131 | renal tubule development (GO:0061326) | 2.91141211 |
| 132 | glucocorticoid biosynthetic process (GO:0006704) | 2.86621210 |
| 133 | nucleobase catabolic process (GO:0046113) | 2.85537592 |
| 134 | regulation of neurotransmitter uptake (GO:0051580) | 2.85519416 |
| 135 | dopamine biosynthetic process (GO:0042416) | 2.84930575 |
| 136 | bile acid biosynthetic process (GO:0006699) | 2.84623385 |
| 137 | succinate metabolic process (GO:0006105) | 2.84329454 |
| 138 | sympathetic nervous system development (GO:0048485) | 2.84103505 |
| 139 | benzene-containing compound metabolic process (GO:0042537) | 2.83693710 |
| 140 | DNA double-strand break processing (GO:0000729) | 2.82900404 |
| 141 | epithelial cilium movement (GO:0003351) | 2.82793012 |
| 142 | proline transport (GO:0015824) | 2.81366731 |
| 143 | modified amino acid transport (GO:0072337) | 2.80938220 |
| 144 | retina layer formation (GO:0010842) | 2.80062915 |
| 145 | cellular ketone body metabolic process (GO:0046950) | 2.79848190 |
| 146 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.77992792 |
| 147 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.77992792 |
| 148 | nephron tubule morphogenesis (GO:0072078) | 2.77787388 |
| 149 | nephron epithelium morphogenesis (GO:0072088) | 2.77787388 |
| 150 | drug metabolic process (GO:0017144) | 2.76175614 |
| 151 | phasic smooth muscle contraction (GO:0014821) | 2.75723843 |
| 152 | cAMP biosynthetic process (GO:0006171) | 2.75208634 |
| 153 | polyol transport (GO:0015791) | 2.73331752 |
| 154 | NADH metabolic process (GO:0006734) | 2.72384761 |
| 155 | negative regulation of axon guidance (GO:1902668) | 2.72227721 |
| 156 | nephron epithelium development (GO:0072009) | 2.71359084 |
| 157 | regulation of mitochondrial fission (GO:0090140) | 2.70592244 |
| 158 | glutamate metabolic process (GO:0006536) | 2.70230279 |
| 159 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.69977035 |
| 160 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.69977035 |
| 161 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.68998318 |
| 162 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.68876341 |
| 163 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.68876341 |
| 164 | response to growth hormone (GO:0060416) | 2.68641893 |
| 165 | sulfur amino acid catabolic process (GO:0000098) | 2.68246794 |
| 166 | prenylation (GO:0097354) | 2.68232248 |
| 167 | protein prenylation (GO:0018342) | 2.68232248 |
| 168 | positive regulation of membrane potential (GO:0045838) | 2.67586644 |
| 169 | neuronal action potential (GO:0019228) | 2.67361445 |
| 170 | left/right axis specification (GO:0070986) | 2.66611088 |
| 171 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.63889646 |
| 172 | transmission of nerve impulse (GO:0019226) | 2.63267681 |
| 173 | olfactory bulb development (GO:0021772) | 2.61228147 |
| 174 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.61140363 |
| 175 | presynaptic membrane assembly (GO:0097105) | 2.58754743 |
| 176 | ketone body metabolic process (GO:1902224) | 2.56443253 |
| 177 | cilium organization (GO:0044782) | 2.55805738 |
| 178 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.54968547 |
| 179 | cilium assembly (GO:0042384) | 2.53989675 |
| 180 | adaptation of signaling pathway (GO:0023058) | 2.53433838 |
| 181 | embryonic epithelial tube formation (GO:0001838) | 2.52410156 |
| 182 | hepatocyte apoptotic process (GO:0097284) | 2.51312732 |
| 183 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.51199851 |
| 184 | cilium morphogenesis (GO:0060271) | 2.50334366 |
| 185 | protein polyglutamylation (GO:0018095) | 2.49806797 |
| 186 | protein-cofactor linkage (GO:0018065) | 2.49692916 |
| 187 | neuronal ion channel clustering (GO:0045161) | 2.49448515 |
| 188 | DNA integration (GO:0015074) | 2.49422784 |
| 189 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.48507385 |
| 190 | response to auditory stimulus (GO:0010996) | 2.47668889 |
| 191 | gamma-aminobutyric acid transport (GO:0015812) | 2.47179749 |
| 192 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 2.44972059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.76800556 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93617715 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.65173552 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.44218616 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.39753005 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.20960787 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.10778205 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.10556852 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.08140558 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07462859 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 3.06471004 |
| 12 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.86317572 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.55678805 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55534225 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.52545067 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.34219138 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.29268619 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.26069008 |
| 19 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.06353519 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.06033142 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05928128 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.02917627 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.01983954 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 2.00867899 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99104110 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.98484606 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.96973399 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93800035 |
| 29 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.93252909 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87911334 |
| 31 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83495353 |
| 32 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.83495353 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.82628167 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.80882536 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.77896111 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76697755 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.75512668 |
| 38 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73942068 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.73749970 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73277255 |
| 41 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.72506780 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66510186 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64870102 |
| 44 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.63312736 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62126526 |
| 46 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60897666 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59234983 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58333868 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58282013 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57245797 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56371978 |
| 52 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.56332833 |
| 53 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56091370 |
| 54 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.55512783 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.52798085 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52521893 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51469817 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49582623 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47304465 |
| 60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46886971 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46717286 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46293437 |
| 63 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.46137186 |
| 64 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.46137186 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45925335 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45378850 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44963100 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44443874 |
| 69 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44057451 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43957251 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43814548 |
| 72 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.43633361 |
| 73 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.42932710 |
| 74 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42683057 |
| 75 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41991012 |
| 76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40150994 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.39604994 |
| 78 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38796394 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.36517856 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.36143283 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32147241 |
| 82 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.29860204 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.27169899 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26896633 |
| 85 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.25979400 |
| 86 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25649289 |
| 87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.24869802 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23953799 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.23411486 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22902501 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22792413 |
| 92 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22697193 |
| 93 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22301432 |
| 94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21881619 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21371902 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21362113 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21362113 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21261959 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20408202 |
| 100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20212298 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20059316 |
| 102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19567009 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19365687 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19280733 |
| 105 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19241651 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18806302 |
| 107 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16743444 |
| 108 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16308689 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16243031 |
| 110 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.14547553 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14158451 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14144881 |
| 113 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13881525 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13709541 |
| 115 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13242097 |
| 116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12878655 |
| 117 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12706106 |
| 118 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12549038 |
| 119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12242462 |
| 120 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11716424 |
| 121 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10751346 |
| 122 | * EGR1_19032775_ChIP-ChIP_M12_Human | 1.10214968 |
| 123 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.10203201 |
| 124 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10126422 |
| 125 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09579501 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08630810 |
| 127 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07709121 |
| 128 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07594945 |
| 129 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07443251 |
| 130 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07146962 |
| 131 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.06710101 |
| 132 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06220310 |
| 133 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.06147139 |
| 134 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06122790 |
| 135 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05418575 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04509723 |
| 137 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03575100 |
| 138 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02187331 |
| 139 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01685618 |
| 140 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01442946 |
| 141 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01328399 |
| 142 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00482055 |
| 143 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99927451 |
| 144 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99818874 |
| 145 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.99235878 |
| 146 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99055472 |
| 147 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99055472 |
| 148 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98949171 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96301886 |
| 150 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95595847 |
| 151 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95432591 |
| 152 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.94277319 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93345885 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93345885 |
| 155 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92299969 |
| 156 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.91628576 |
| 157 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91553116 |
| 158 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90800342 |
| 159 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90302303 |
| 160 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90254287 |
| 161 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.89559495 |
| 162 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.88889754 |
| 163 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88517716 |
| 164 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.86746735 |
| 165 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85971153 |
| 166 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85867714 |
| 167 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84877640 |
| 168 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84010050 |
| 169 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83505757 |
| 170 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82707849 |
| 171 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82000694 |
| 172 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81859377 |
| 173 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.80875436 |
| 174 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80445125 |
| 175 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80151018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.91905198 |
| 2 | MP0004043_abnormal_pH_regulation | 5.37492407 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.84724891 |
| 4 | MP0003195_calcinosis | 4.70092166 |
| 5 | MP0002822_catalepsy | 4.65506518 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.96528929 |
| 7 | MP0002876_abnormal_thyroid_physiology | 3.65377167 |
| 8 | MP0005332_abnormal_amino_acid | 3.64527188 |
| 9 | MP0001765_abnormal_ion_homeostasis | 3.26143746 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.20103864 |
| 11 | MP0009643_abnormal_urine_homeostasis | 3.19725806 |
| 12 | MP0002102_abnormal_ear_morphology | 3.11839963 |
| 13 | MP0009379_abnormal_foot_pigmentation | 3.10302050 |
| 14 | MP0003880_abnormal_central_pattern | 3.07756503 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.89277634 |
| 16 | MP0005636_abnormal_mineral_homeostasis | 2.75723497 |
| 17 | MP0003252_abnormal_bile_duct | 2.63301570 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.48700534 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 2.47361888 |
| 20 | MP0004133_heterotaxia | 2.44326506 |
| 21 | MP0005365_abnormal_bile_salt | 2.37399731 |
| 22 | MP0001756_abnormal_urination | 2.36071631 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.35687760 |
| 24 | MP0005646_abnormal_pituitary_gland | 2.35007505 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.31356445 |
| 26 | MP0001188_hyperpigmentation | 2.30061944 |
| 27 | MP0001529_abnormal_vocalization | 2.29830887 |
| 28 | MP0002736_abnormal_nociception_after | 2.29740655 |
| 29 | MP0002735_abnormal_chemical_nociception | 2.27025933 |
| 30 | MP0000678_abnormal_parathyroid_gland | 2.17608908 |
| 31 | MP0002136_abnormal_kidney_physiology | 2.17592304 |
| 32 | MP0002751_abnormal_autonomic_nervous | 2.17484364 |
| 33 | MP0005058_abnormal_lysosome_morphology | 2.07868511 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 2.05585633 |
| 35 | MP0005253_abnormal_eye_physiology | 1.95903241 |
| 36 | MP0010386_abnormal_urinary_bladder | 1.84135758 |
| 37 | MP0005409_darkened_coat_color | 1.74981318 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.74874468 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.71528736 |
| 40 | MP0001905_abnormal_dopamine_level | 1.70621592 |
| 41 | MP0004147_increased_porphyrin_level | 1.69700403 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.66806511 |
| 43 | MP0009745_abnormal_behavioral_response | 1.63560249 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.61082194 |
| 45 | MP0000538_abnormal_urinary_bladder | 1.56087224 |
| 46 | MP0001486_abnormal_startle_reflex | 1.54852597 |
| 47 | MP0001764_abnormal_homeostasis | 1.53244349 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.52876275 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.50413002 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.48929143 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.48606443 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.48145677 |
| 53 | MP0003787_abnormal_imprinting | 1.47587375 |
| 54 | MP0005187_abnormal_penis_morphology | 1.46376691 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.42839408 |
| 56 | MP0003878_abnormal_ear_physiology | 1.42839408 |
| 57 | MP0003121_genomic_imprinting | 1.42739437 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.40153813 |
| 59 | MP0004924_abnormal_behavior | 1.40153813 |
| 60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.40127119 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.38286092 |
| 62 | MP0002272_abnormal_nervous_system | 1.37173824 |
| 63 | MP0008872_abnormal_physiological_respon | 1.34395828 |
| 64 | MP0002928_abnormal_bile_duct | 1.32881604 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.32682567 |
| 66 | MP0002734_abnormal_mechanical_nocicepti | 1.29992189 |
| 67 | MP0000647_abnormal_sebaceous_gland | 1.27272585 |
| 68 | MP0002938_white_spotting | 1.27186724 |
| 69 | MP0000230_abnormal_systemic_arterial | 1.24033165 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 1.23947049 |
| 71 | MP0003122_maternal_imprinting | 1.23352652 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23297471 |
| 73 | MP0001501_abnormal_sleep_pattern | 1.22737975 |
| 74 | MP0004130_abnormal_muscle_cell | 1.22600001 |
| 75 | MP0001970_abnormal_pain_threshold | 1.21537246 |
| 76 | MP0003186_abnormal_redox_activity | 1.21457356 |
| 77 | MP0001666_abnormal_nutrient_absorption | 1.21086724 |
| 78 | MP0000015_abnormal_ear_pigmentation | 1.20723391 |
| 79 | MP0002184_abnormal_innervation | 1.20590093 |
| 80 | MP0002009_preneoplasia | 1.20044844 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.18205072 |
| 82 | MP0008995_early_reproductive_senescence | 1.17854334 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.17847411 |
| 84 | MP0009764_decreased_sensitivity_to | 1.17273023 |
| 85 | MP0005451_abnormal_body_composition | 1.16795304 |
| 86 | MP0000778_abnormal_nervous_system | 1.16523445 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 1.14572235 |
| 88 | MP0000681_abnormal_thyroid_gland | 1.14433349 |
| 89 | MP0001944_abnormal_pancreas_morphology | 1.12971540 |
| 90 | MP0002557_abnormal_social/conspecific_i | 1.12696835 |
| 91 | MP0005535_abnormal_body_temperature | 1.11479731 |
| 92 | MP0009046_muscle_twitch | 1.11306665 |
| 93 | MP0003283_abnormal_digestive_organ | 1.09448204 |
| 94 | MP0000516_abnormal_urinary_system | 1.08902309 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 1.08902309 |
| 96 | MP0004142_abnormal_muscle_tone | 1.07148093 |
| 97 | MP0006054_spinal_hemorrhage | 1.05619608 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 1.05451055 |
| 99 | MP0004742_abnormal_vestibular_system | 1.03621011 |
| 100 | MP0003172_abnormal_lysosome_physiology | 1.02997112 |
| 101 | MP0002063_abnormal_learning/memory/cond | 1.01977736 |
| 102 | MP0005171_absent_coat_pigmentation | 1.01575938 |
| 103 | MP0000427_abnormal_hair_cycle | 1.01231243 |
| 104 | MP0001958_emphysema | 1.00929539 |
| 105 | MP0003890_abnormal_embryonic-extraembry | 0.99942441 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.99858656 |
| 107 | MP0003136_yellow_coat_color | 0.99503395 |
| 108 | MP0001873_stomach_inflammation | 0.99374538 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.97932363 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.97187621 |
| 111 | MP0003879_abnormal_hair_cell | 0.97099714 |
| 112 | MP0005670_abnormal_white_adipose | 0.96562443 |
| 113 | MP0005310_abnormal_salivary_gland | 0.96194464 |
| 114 | MP0003724_increased_susceptibility_to | 0.95636765 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.95438894 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.95190707 |
| 117 | MP0005423_abnormal_somatic_nervous | 0.95188567 |
| 118 | MP0001984_abnormal_olfaction | 0.94600863 |
| 119 | MP0008469_abnormal_protein_level | 0.94145408 |
| 120 | MP0002064_seizures | 0.93840026 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.93275443 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.92896870 |
| 123 | MP0004270_analgesia | 0.92529373 |
| 124 | MP0001270_distended_abdomen | 0.91779133 |
| 125 | MP0005448_abnormal_energy_balance | 0.91716388 |
| 126 | MP0002118_abnormal_lipid_homeostasis | 0.90348462 |
| 127 | MP0002653_abnormal_ependyma_morphology | 0.90113348 |
| 128 | MP0002752_abnormal_somatic_nervous | 0.89300712 |
| 129 | MP0005195_abnormal_posterior_eye | 0.88532346 |
| 130 | MP0002882_abnormal_neuron_morphology | 0.87637406 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.87030158 |
| 132 | MP0003959_abnormal_lean_body | 0.87017097 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.85792027 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.84808525 |
| 135 | MP0002078_abnormal_glucose_homeostasis | 0.83302505 |
| 136 | MP0002135_abnormal_kidney_morphology | 0.83292290 |
| 137 | MP0002168_other_aberrant_phenotype | 0.82459633 |
| 138 | MP0002638_abnormal_pupillary_reflex | 0.81716866 |
| 139 | MP0006292_abnormal_olfactory_placode | 0.79937499 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.79806685 |
| 141 | MP0002234_abnormal_pharynx_morphology | 0.78937980 |
| 142 | MP0001986_abnormal_taste_sensitivity | 0.78894284 |
| 143 | MP0005408_hypopigmentation | 0.78644330 |
| 144 | MP0001324_abnormal_eye_pigmentation | 0.78112428 |
| 145 | MP0005391_vision/eye_phenotype | 0.75870122 |
| 146 | MP0005387_immune_system_phenotype | 0.75812646 |
| 147 | MP0001790_abnormal_immune_system | 0.75812646 |
| 148 | MP0000026_abnormal_inner_ear | 0.75431022 |
| 149 | MP0001440_abnormal_grooming_behavior | 0.75320977 |
| 150 | MP0002095_abnormal_skin_pigmentation | 0.75044692 |
| 151 | MP0002998_abnormal_bone_remodeling | 0.74656562 |
| 152 | MP0000609_abnormal_liver_physiology | 0.73939715 |
| 153 | MP0004145_abnormal_muscle_electrophysio | 0.73739190 |
| 154 | MP0001845_abnormal_inflammatory_respons | 0.72801218 |
| 155 | MP0010329_abnormal_lipoprotein_level | 0.72448504 |
| 156 | MP0005083_abnormal_biliary_tract | 0.71525199 |
| 157 | MP0003718_maternal_effect | 0.71067889 |
| 158 | MP0003953_abnormal_hormone_level | 0.70175476 |
| 159 | MP0008961_abnormal_basal_metabolism | 0.69088429 |
| 160 | MP0003868_abnormal_feces_composition | 0.67618762 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.66409778 |
| 162 | MP0004885_abnormal_endolymph | 0.65787693 |
| 163 | MP0001835_abnormal_antigen_presentation | 0.64672042 |
| 164 | MP0001485_abnormal_pinna_reflex | 0.64315154 |
| 165 | MP0000685_abnormal_immune_system | 0.61656443 |
| 166 | MP0009785_altered_susceptibility_to | 0.59557606 |
| 167 | MP0002163_abnormal_gland_morphology | 0.58532986 |
| 168 | MP0000371_diluted_coat_color | 0.56911508 |
| 169 | MP0003795_abnormal_bone_structure | 0.55782847 |
| 170 | MP0004782_abnormal_surfactant_physiolog | 0.53826351 |
| 171 | MP0009765_abnormal_xenobiotic_induced | 0.51015471 |
| 172 | MP0003866_abnormal_defecation | 0.50246437 |
| 173 | MP0001664_abnormal_digestion | 0.49457447 |
| 174 | MP0000598_abnormal_liver_morphology | 0.48284808 |
| 175 | MP0002148_abnormal_hypersensitivity_rea | 0.47928610 |
| 176 | MP0006035_abnormal_mitochondrial_morpho | 0.46585895 |
| 177 | MP0006082_CNS_inflammation | 0.46203572 |
| 178 | MP0001663_abnormal_digestive_system | 0.45677864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.30594530 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 6.14932044 |
| 3 | Abnormality of magnesium homeostasis (HP:0004921) | 6.11482548 |
| 4 | Metabolic alkalosis (HP:0200114) | 6.10664564 |
| 5 | Hypomagnesemia (HP:0002917) | 5.99998087 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 5.98242339 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 5.62843441 |
| 8 | Gout (HP:0001997) | 5.29633100 |
| 9 | Polyuria (HP:0000103) | 5.09888911 |
| 10 | Proximal tubulopathy (HP:0000114) | 4.87182109 |
| 11 | Abnormal urine output (HP:0012590) | 4.85426853 |
| 12 | Abnormality of renal excretion (HP:0011036) | 4.66469009 |
| 13 | Tetany (HP:0001281) | 4.58722330 |
| 14 | Abnormality of renin-angiotensin system (HP:0000847) | 4.43499325 |
| 15 | Generalized aminoaciduria (HP:0002909) | 4.38095014 |
| 16 | Alkalosis (HP:0001948) | 4.35312941 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.34580082 |
| 18 | Hyperglycinuria (HP:0003108) | 4.24644859 |
| 19 | Polydipsia (HP:0001959) | 4.23916288 |
| 20 | Abnormal drinking behavior (HP:0030082) | 4.23916288 |
| 21 | Hyperaldosteronism (HP:0000859) | 4.23907291 |
| 22 | Molar tooth sign on MRI (HP:0002419) | 4.19038936 |
| 23 | Abnormality of midbrain morphology (HP:0002418) | 4.19038936 |
| 24 | Renal salt wasting (HP:0000127) | 4.11702650 |
| 25 | Ketoacidosis (HP:0001993) | 3.95583532 |
| 26 | Intestinal atresia (HP:0011100) | 3.94085370 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.87883195 |
| 28 | Pancreatic cysts (HP:0001737) | 3.85319748 |
| 29 | Increased purine levels (HP:0004368) | 3.85178038 |
| 30 | Hyperuricemia (HP:0002149) | 3.85178038 |
| 31 | Nephronophthisis (HP:0000090) | 3.80984234 |
| 32 | Hypercalciuria (HP:0002150) | 3.70098747 |
| 33 | Pancreatic fibrosis (HP:0100732) | 3.68610879 |
| 34 | True hermaphroditism (HP:0010459) | 3.63828986 |
| 35 | Hypothermia (HP:0002045) | 3.60460992 |
| 36 | Hypokalemia (HP:0002900) | 3.42005542 |
| 37 | Amelogenesis imperfecta (HP:0000705) | 3.33773626 |
| 38 | Glycosuria (HP:0003076) | 3.30262555 |
| 39 | Abnormality of urine glucose concentration (HP:0011016) | 3.30262555 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.30034864 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.30034864 |
| 42 | Unilateral renal agenesis (HP:0000122) | 3.23354831 |
| 43 | Ketosis (HP:0001946) | 3.19146159 |
| 44 | Abnormality of the renal medulla (HP:0100957) | 3.17464638 |
| 45 | Inability to walk (HP:0002540) | 3.08747084 |
| 46 | Hydroxyprolinuria (HP:0003080) | 3.07630364 |
| 47 | Abnormality of proline metabolism (HP:0010907) | 3.07630364 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 3.06703123 |
| 49 | Abnormality of potassium homeostasis (HP:0011042) | 3.06078661 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.03979225 |
| 51 | Chronic hepatic failure (HP:0100626) | 3.01810597 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.99330177 |
| 53 | Renal tubular acidosis (HP:0001947) | 2.97983770 |
| 54 | Limb dystonia (HP:0002451) | 2.96711402 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94352681 |
| 56 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.88684258 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.87205350 |
| 58 | Hyperphosphatemia (HP:0002905) | 2.87049728 |
| 59 | Focal motor seizures (HP:0011153) | 2.84246705 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.81477923 |
| 61 | Hyperventilation (HP:0002883) | 2.80947963 |
| 62 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.78532534 |
| 63 | Abnormality of alanine metabolism (HP:0010916) | 2.78532534 |
| 64 | Hyperalaninemia (HP:0003348) | 2.78532534 |
| 65 | Metaphyseal cupping (HP:0003021) | 2.72860688 |
| 66 | Hyperphosphaturia (HP:0003109) | 2.72333270 |
| 67 | Intrahepatic cholestasis (HP:0001406) | 2.69232860 |
| 68 | Oligodactyly (hands) (HP:0001180) | 2.68073969 |
| 69 | Congenital sensorineural hearing impairment (HP:0008527) | 2.67662791 |
| 70 | Abolished electroretinogram (ERG) (HP:0000550) | 2.66779025 |
| 71 | Abnormality of dental color (HP:0011073) | 2.66175607 |
| 72 | Nephrolithiasis (HP:0000787) | 2.60016093 |
| 73 | Drooling (HP:0002307) | 2.58889478 |
| 74 | Abnormal urine phosphate concentration (HP:0012599) | 2.55107675 |
| 75 | Enlarged kidneys (HP:0000105) | 2.52819923 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52478910 |
| 77 | Hypophosphatemia (HP:0002148) | 2.50427779 |
| 78 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.49437501 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48096418 |
| 80 | Hypoglycemic coma (HP:0001325) | 2.46265499 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.45790807 |
| 82 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.43549522 |
| 83 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.43549522 |
| 84 | Febrile seizures (HP:0002373) | 2.40004781 |
| 85 | Symptomatic seizures (HP:0011145) | 2.36797763 |
| 86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.36668377 |
| 87 | Absent/shortened dynein arms (HP:0200106) | 2.36668377 |
| 88 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.36626311 |
| 89 | Excessive salivation (HP:0003781) | 2.36203378 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 2.34918743 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34918743 |
| 92 | Renal cortical cysts (HP:0000803) | 2.32550690 |
| 93 | Progressive inability to walk (HP:0002505) | 2.31978211 |
| 94 | Decreased circulating renin level (HP:0003351) | 2.31645098 |
| 95 | Volvulus (HP:0002580) | 2.31069273 |
| 96 | Gait imbalance (HP:0002141) | 2.30836234 |
| 97 | Thyroiditis (HP:0100646) | 2.30299370 |
| 98 | Abnormal ciliary motility (HP:0012262) | 2.30263315 |
| 99 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.29112915 |
| 100 | Nephrocalcinosis (HP:0000121) | 2.29077824 |
| 101 | Constricted visual fields (HP:0001133) | 2.27940656 |
| 102 | Vascular calcification (HP:0004934) | 2.27566339 |
| 103 | Delayed epiphyseal ossification (HP:0002663) | 2.25027659 |
| 104 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.24434591 |
| 105 | Dysostosis multiplex (HP:0000943) | 2.24138901 |
| 106 | Gastrointestinal atresia (HP:0002589) | 2.21281886 |
| 107 | Metabolic acidosis (HP:0001942) | 2.20383190 |
| 108 | Anencephaly (HP:0002323) | 2.19933415 |
| 109 | Cystic liver disease (HP:0006706) | 2.19321674 |
| 110 | Congenital primary aphakia (HP:0007707) | 2.18938656 |
| 111 | Genital tract atresia (HP:0001827) | 2.18713814 |
| 112 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17284076 |
| 113 | Supernumerary spleens (HP:0009799) | 2.17257285 |
| 114 | Methylmalonic acidemia (HP:0002912) | 2.17207264 |
| 115 | Delayed CNS myelination (HP:0002188) | 2.16919941 |
| 116 | Dehydration (HP:0001944) | 2.14441379 |
| 117 | Increased corneal curvature (HP:0100692) | 2.13972004 |
| 118 | Keratoconus (HP:0000563) | 2.13972004 |
| 119 | Abnormal tarsal ossification (HP:0008369) | 2.13955369 |
| 120 | Rhinitis (HP:0012384) | 2.12692130 |
| 121 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.11836987 |
| 122 | Rickets (HP:0002748) | 2.11276260 |
| 123 | Hyperammonemia (HP:0001987) | 2.11167413 |
| 124 | Widely patent fontanelles and sutures (HP:0004492) | 2.10732052 |
| 125 | Hyperkalemia (HP:0002153) | 2.10319369 |
| 126 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.10269448 |
| 127 | Abnormality of the renal cortex (HP:0011035) | 2.10208789 |
| 128 | Mucopolysacchariduria (HP:0008155) | 2.07702807 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07702807 |
| 130 | Hyperglycinemia (HP:0002154) | 2.07626383 |
| 131 | Prolonged neonatal jaundice (HP:0006579) | 2.06397510 |
| 132 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.05785882 |
| 133 | Hypoplasia of the uterus (HP:0000013) | 2.04199758 |
| 134 | Adrenal overactivity (HP:0002717) | 2.01723233 |
| 135 | Vomiting (HP:0002013) | 2.01166576 |
| 136 | Vaginal atresia (HP:0000148) | 2.00892668 |
| 137 | Overgrowth (HP:0001548) | 2.00661574 |
| 138 | Sclerocornea (HP:0000647) | 2.00400480 |
| 139 | Hypoglycemic seizures (HP:0002173) | 2.00371162 |
| 140 | Pancreatitis (HP:0001733) | 2.00336085 |
| 141 | Confusion (HP:0001289) | 1.99768338 |
| 142 | Tachypnea (HP:0002789) | 1.99623172 |
| 143 | Malnutrition (HP:0004395) | 1.99601575 |
| 144 | Abnormality of renal resorption (HP:0011038) | 1.99336434 |
| 145 | Late onset (HP:0003584) | 1.99249693 |
| 146 | Focal seizures (HP:0007359) | 1.99167611 |
| 147 | Pendular nystagmus (HP:0012043) | 1.98296869 |
| 148 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.97746880 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96205101 |
| 150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96205101 |
| 151 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96205101 |
| 152 | Hyponatremia (HP:0002902) | 1.95561120 |
| 153 | Absent speech (HP:0001344) | 1.95518028 |
| 154 | Methylmalonic aciduria (HP:0012120) | 1.94760789 |
| 155 | Chorioretinal coloboma (HP:0000567) | 1.93325382 |
| 156 | Renal tubular dysfunction (HP:0000124) | 1.92926637 |
| 157 | Cardiovascular calcification (HP:0011915) | 1.92082800 |
| 158 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91375482 |
| 159 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91292728 |
| 160 | Lissencephaly (HP:0001339) | 1.91202103 |
| 161 | Postaxial foot polydactyly (HP:0001830) | 1.90536434 |
| 162 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.89576953 |
| 163 | Metaphyseal dysplasia (HP:0100255) | 1.89067198 |
| 164 | Lethargy (HP:0001254) | 1.88515562 |
| 165 | Polyphagia (HP:0002591) | 1.87851468 |
| 166 | Broad-based gait (HP:0002136) | 1.87416776 |
| 167 | Type II lissencephaly (HP:0007260) | 1.86990001 |
| 168 | Gaze-evoked nystagmus (HP:0000640) | 1.86406397 |
| 169 | Elevated alkaline phosphatase (HP:0003155) | 1.86218086 |
| 170 | Congenital hepatic fibrosis (HP:0002612) | 1.86057901 |
| 171 | Decreased central vision (HP:0007663) | 1.85569942 |
| 172 | Progressive cerebellar ataxia (HP:0002073) | 1.85387530 |
| 173 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83963749 |
| 174 | Occipital encephalocele (HP:0002085) | 1.83148458 |
| 175 | Small hand (HP:0200055) | 1.82815600 |
| 176 | Narrow forehead (HP:0000341) | 1.80019444 |
| 177 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.79381405 |
| 178 | Male pseudohermaphroditism (HP:0000037) | 1.78624060 |
| 179 | Widely spaced teeth (HP:0000687) | 1.77534962 |
| 180 | Esophageal atresia (HP:0002032) | 1.77184806 |
| 181 | Agitation (HP:0000713) | 1.77007713 |
| 182 | Postaxial hand polydactyly (HP:0001162) | 1.75337526 |
| 183 | Dialeptic seizures (HP:0011146) | 1.74926246 |
| 184 | Hypoplasia of the fovea (HP:0007750) | 1.73897766 |
| 185 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.73897766 |
| 186 | Anophthalmia (HP:0000528) | 1.73629270 |
| 187 | Furrowed tongue (HP:0000221) | 1.72623036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 7.37182763 |
| 2 | WNK3 | 6.23373444 |
| 3 | NTRK2 | 4.81056807 |
| 4 | OXSR1 | 4.76085621 |
| 5 | BCKDK | 3.89972362 |
| 6 | TRIM28 | 2.98610738 |
| 7 | FLT3 | 2.97807580 |
| 8 | CASK | 2.92152889 |
| 9 | MAP4K2 | 2.83685635 |
| 10 | PINK1 | 2.68438757 |
| 11 | STK38L | 2.61156498 |
| 12 | IRAK3 | 2.39976541 |
| 13 | STK39 | 2.33571453 |
| 14 | INSRR | 2.24663434 |
| 15 | MARK1 | 2.24534185 |
| 16 | MAPK13 | 2.10296905 |
| 17 | ACVR1B | 1.97649187 |
| 18 | TAOK3 | 1.97614148 |
| 19 | KIT | 1.92733396 |
| 20 | BCR | 1.85885261 |
| 21 | BMPR1B | 1.69538908 |
| 22 | NUAK1 | 1.67893833 |
| 23 | SIK3 | 1.62085735 |
| 24 | MAP3K4 | 1.59366930 |
| 25 | PAK3 | 1.57536227 |
| 26 | WNK1 | 1.47017019 |
| 27 | STK3 | 1.41287061 |
| 28 | CSNK1G2 | 1.40812211 |
| 29 | AKT3 | 1.38132760 |
| 30 | FRK | 1.36416928 |
| 31 | NME2 | 1.31800755 |
| 32 | TEC | 1.30288557 |
| 33 | PLK2 | 1.29228968 |
| 34 | PIK3CG | 1.28456946 |
| 35 | MKNK2 | 1.23030168 |
| 36 | ADRBK2 | 1.22692628 |
| 37 | MAP3K14 | 1.21909711 |
| 38 | PLK4 | 1.19597778 |
| 39 | IRAK1 | 1.19315273 |
| 40 | FGFR4 | 1.18695226 |
| 41 | DYRK2 | 1.18414032 |
| 42 | TGFBR2 | 1.18328953 |
| 43 | TXK | 1.17423944 |
| 44 | MAPKAPK5 | 1.16332601 |
| 45 | IRAK4 | 1.15800770 |
| 46 | NEK1 | 1.15045532 |
| 47 | CSNK1A1L | 1.09737457 |
| 48 | GRK1 | 1.09521936 |
| 49 | NTRK3 | 1.07626801 |
| 50 | TIE1 | 1.05262094 |
| 51 | ZAK | 1.02609277 |
| 52 | MARK3 | 1.02401284 |
| 53 | ERN1 | 1.02367871 |
| 54 | DYRK3 | 0.97796097 |
| 55 | MAP2K7 | 0.97614249 |
| 56 | TNIK | 0.97355318 |
| 57 | MST1R | 0.96122106 |
| 58 | STK16 | 0.94422274 |
| 59 | MKNK1 | 0.92406632 |
| 60 | BTK | 0.88121693 |
| 61 | VRK1 | 0.86259897 |
| 62 | SGK494 | 0.85588185 |
| 63 | SGK223 | 0.85588185 |
| 64 | DYRK1A | 0.85174431 |
| 65 | MAPK15 | 0.83724289 |
| 66 | SIK1 | 0.82350064 |
| 67 | MINK1 | 0.81640737 |
| 68 | PHKG2 | 0.81054919 |
| 69 | PHKG1 | 0.81054919 |
| 70 | MAP3K7 | 0.80591380 |
| 71 | STK38 | 0.76607147 |
| 72 | MUSK | 0.76506673 |
| 73 | PRKCG | 0.75310095 |
| 74 | DYRK1B | 0.74885313 |
| 75 | CAMK2A | 0.73597749 |
| 76 | CSF1R | 0.70981914 |
| 77 | TLK1 | 0.70516253 |
| 78 | ADRBK1 | 0.70475938 |
| 79 | TBK1 | 0.70314642 |
| 80 | PDK3 | 0.67976760 |
| 81 | PDK4 | 0.67976760 |
| 82 | BMPR2 | 0.67605657 |
| 83 | SGK2 | 0.67353203 |
| 84 | MST4 | 0.66233764 |
| 85 | TAF1 | 0.65784929 |
| 86 | DAPK2 | 0.63095656 |
| 87 | PRKD2 | 0.62488874 |
| 88 | PDK2 | 0.61404687 |
| 89 | NLK | 0.60473355 |
| 90 | CSNK1A1 | 0.58743642 |
| 91 | SIK2 | 0.58668950 |
| 92 | PRKAA1 | 0.57577424 |
| 93 | STK24 | 0.56933085 |
| 94 | PRKACA | 0.56118851 |
| 95 | CCNB1 | 0.56032739 |
| 96 | UHMK1 | 0.55745267 |
| 97 | MAPK11 | 0.53452120 |
| 98 | EPHB1 | 0.52748346 |
| 99 | JAK3 | 0.52612382 |
| 100 | BLK | 0.52348859 |
| 101 | TYK2 | 0.52328965 |
| 102 | BRSK2 | 0.51434550 |
| 103 | ZAP70 | 0.51353890 |
| 104 | PLK3 | 0.50367179 |
| 105 | PKN1 | 0.50244104 |
| 106 | EPHA3 | 0.49855248 |
| 107 | PTK2 | 0.48300681 |
| 108 | PASK | 0.47331885 |
| 109 | PRKAA2 | 0.46899700 |
| 110 | IRAK2 | 0.46497964 |
| 111 | EPHA2 | 0.44793930 |
| 112 | PTK2B | 0.44730623 |
| 113 | KSR1 | 0.44593453 |
| 114 | SYK | 0.44543244 |
| 115 | CAMK2B | 0.44029190 |
| 116 | PRKACB | 0.42601190 |
| 117 | ERBB2 | 0.42441710 |
| 118 | IKBKE | 0.42410468 |
| 119 | PTK6 | 0.42028945 |
| 120 | EIF2AK3 | 0.41919690 |
| 121 | PRKG1 | 0.41884541 |
| 122 | SGK3 | 0.40168815 |
| 123 | GSK3A | 0.39927283 |
| 124 | CAMK4 | 0.39579898 |
| 125 | HIPK2 | 0.39363483 |
| 126 | PRKCD | 0.38266037 |
| 127 | PRKCE | 0.38179457 |
| 128 | ITK | 0.38075060 |
| 129 | RPS6KA5 | 0.38002305 |
| 130 | YES1 | 0.36493423 |
| 131 | PRKACG | 0.35844270 |
| 132 | MAP2K4 | 0.35827137 |
| 133 | CSNK1D | 0.34535776 |
| 134 | EPHB2 | 0.34415738 |
| 135 | MAP3K3 | 0.34249435 |
| 136 | FER | 0.34054086 |
| 137 | SRPK1 | 0.33828723 |
| 138 | CDK5 | 0.33454095 |
| 139 | OBSCN | 0.33435941 |
| 140 | EIF2AK2 | 0.33427985 |
| 141 | PRKG2 | 0.33062834 |
| 142 | ERBB3 | 0.31648149 |
| 143 | LYN | 0.31579384 |
| 144 | CAMKK2 | 0.31524688 |
| 145 | MAP3K12 | 0.31346100 |
| 146 | CAMK2D | 0.31215868 |
| 147 | PRKCA | 0.31195911 |
| 148 | ABL1 | 0.31153604 |
| 149 | CSNK1G1 | 0.31030484 |
| 150 | EGFR | 0.30828727 |
| 151 | PRKCB | 0.30144597 |
| 152 | IKBKB | 0.29729410 |
| 153 | JAK2 | 0.29700912 |
| 154 | FGFR1 | 0.28788983 |
| 155 | IGF1R | 0.28444573 |
| 156 | SGK1 | 0.28205193 |
| 157 | CHUK | 0.27085229 |
| 158 | PRKCH | 0.27027969 |
| 159 | PRKCI | 0.26915745 |
| 160 | MAP2K2 | 0.25573795 |
| 161 | RIPK1 | 0.23468195 |
| 162 | CSNK1G3 | 0.23305141 |
| 163 | MET | 0.23272313 |
| 164 | MAP4K1 | 0.22999910 |
| 165 | RIPK4 | 0.22842642 |
| 166 | ABL2 | 0.22573197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.21265845 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.14619205 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.13333456 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.06931056 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.97271674 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.92761791 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.87782272 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.85711594 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.73585308 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72569302 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.66165884 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.58618873 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.53487154 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52326429 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.45548676 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 2.44931695 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.41902432 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.40935180 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 2.29286422 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.27229332 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 2.25750013 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22964692 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.22480437 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.16829907 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.15605478 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.13483352 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13149679 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 2.12782417 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.98802697 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97642193 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.87909098 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.82534778 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80383369 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.78387077 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74824553 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.73729954 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71008110 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.69483612 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68061689 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.66639027 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.66438359 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.64812678 |
| 43 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.48502312 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42602191 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33001908 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.32135603 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31979180 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29468236 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25569176 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.25343094 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.23571976 |
| 52 | * Cocaine addiction_Homo sapiens_hsa05030 | 1.21755386 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.19277074 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.18591363 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16877449 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15835834 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11684875 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11062600 |
| 59 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.10813582 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08647061 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06819454 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 1.06565228 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 1.06413370 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05706905 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01271895 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00696895 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00453604 |
| 68 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.99147472 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98973602 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98177764 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97830173 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97677736 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95997247 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.93967664 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93788507 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93262867 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92323440 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91972813 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91820433 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91658302 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91269612 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90872537 |
| 83 | * Amphetamine addiction_Homo sapiens_hsa05031 | 0.90430732 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89837862 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89223555 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88171707 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.87796927 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.86769862 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85885606 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83265221 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.82114906 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76735211 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74698832 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70900637 |
| 95 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70814062 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68214670 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67716545 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67434513 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66854024 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.65833727 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65051540 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64836496 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64552933 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64120994 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.62738401 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.61891163 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60393786 |
| 108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60121201 |
| 109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59338616 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57995833 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57351520 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57186697 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56566521 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55066370 |
| 115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54558314 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53948009 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52632351 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52099784 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51134418 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50537651 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50370465 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49668077 |
| 123 | Axon guidance_Homo sapiens_hsa04360 | 0.48340545 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48282818 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46727409 |
| 126 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46586187 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45407389 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45365011 |
| 129 | RNA polymerase_Homo sapiens_hsa03020 | 0.43870098 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42712887 |
| 131 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42351810 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42154722 |
| 133 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41578892 |
| 134 | Purine metabolism_Homo sapiens_hsa00230 | 0.41409664 |
| 135 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41108213 |
| 136 | Melanogenesis_Homo sapiens_hsa04916 | 0.40626226 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40494370 |
| 138 | * Alcoholism_Homo sapiens_hsa05034 | 0.40145212 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39524576 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37682268 |
| 141 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36522960 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34168083 |
| 143 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33779521 |
| 144 | Insulin secretion_Homo sapiens_hsa04911 | 0.33077602 |
| 145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31187756 |
| 146 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30897621 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30501692 |
| 148 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28146704 |
| 149 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.24928962 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22976523 |
| 151 | Phagosome_Homo sapiens_hsa04145 | 0.21996990 |
| 152 | Tuberculosis_Homo sapiens_hsa05152 | 0.21351763 |
| 153 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.21207552 |
| 154 | Hepatitis C_Homo sapiens_hsa05160 | 0.18147764 |
| 155 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.17949718 |
| 156 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.15480130 |
| 157 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.14311393 |

